Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
8.08
-0.14 (-1.70%)
Jul 28, 2026, 10:41 AM EDT - Market open
Arvinas Market Cap
Arvinas has a market cap or net worth of $521.33 million as of July 28, 2026. Its market cap has decreased by -8.90% in one year.
Market Cap
521.33M
Enterprise Value
-76.14M
1-Year Change
-8.90%
Ranking
Category
Stock Price
$8.08
ChartMarket Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $521.33M, an increase of 1.00%. That is a compound annual growth rate of 0.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 521.33M | -31.56% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relmada Therapeutics | 545.43M |
| Prime Medicine | 543.66M |
| 4D Molecular Therapeutics | 542.63M |
| Shattuck Labs | 539.83M |
| Eikon Therapeutics | 534.89M |
| Verastem | 534.27M |
| Contineum Therapeutics | 518.18M |
| Rezolute | 516.07M |